A 2025 systematic review published in Orthopaedic Journal of Sports Medicine , covering 36 studies from 1993 to 2024, found that BPC-157 promotes healing by boosting growth factors and reducing inflammation, with improved outcomes across muscle, tendon, ligament, and bone injury models in animals.4 The peptide enhances growth hormone receptor expression in tendon fibroblasts a key mechanism for tissue repair and regeneration.5 In the only published human orthopaedic data, seven of twelve patients with chronic knee pain reported relief lasting more than six months after a single BPC-157 injection.4 That is a small sample
10.4 (Cambridge (Global Phasing Ltd, 2023)
Clinical research and ongoing FDA-regulated trials are investigating potential applications in areas such as: Osteoarthritis Long COVID Autoimmune conditions Parkinson's disease Dementia Chronic lung disease Skin rejuvenation Anti-aging & tissue support Exosome Therapy Delivers extracellular vesicles to enhance cell-to-cell signaling and support regeneration
Amylin plays a key role in delaying gastric emptying, regulating postprandial glucagon secretion and enhancing feelings of fullness [1]
The critical point and the one most frequently misunderstood in online discussions is that compounding eligibility is not the same as FDA drug approval
TB-500 is a synthetic version of the naturally occurring peptide Thymosin Beta-4 (T4), which is found in nearly all mammalian cells
